Robert Fildes president chief executive Cetus Corp CTUS.O> told Reuters Squibb Corp interested buying Cetus. Earlier company Squibb buy Cetus five pct equity postion Cetus 40 mln dlrs. "This attempt Squibb major majority holder Cetus" Fildes told Reuters interview. "Squibb approach indication acquire wouldn't interested arrangement" Fildes. Squibb reach comment late comment Fildes. Squibb Cetus' pharmaceutical partner equity position Cetus. Eastman Kodak Co EK> W.R. Grace WR> joint venture Cetus neither own equity position company Fildes. Cetus venture Kodak develp diagnostic product Grace develop agricultural products. Earlier Squibb Cetus announce joint statement agreement principle form joint venture develop biotechnology product fields. As deal Squibb license Cetus' anticancer agent include interleukin-2 development. Squibb sell drug Japan market North American Western Europe. "We wouldn't deal understood Cetus want build fully integrate North America Europe" Fildes. He Squibb partner Squibb major joint venture Japan sale capability market. Fildes Cetus shun licensing arrangement pharmaceutical company want build business. Many corporation invest biotech firms. But Squibb's investment Cetus biotechnology. Fildes attractive Cetus want partner didn't relationship biotechnology companies." Fildes strategy partner non drug area diagnostics agriculture "keep big development anticancer drug ourselves." Fildes partnership Squibb broaden company's reach money make area cardiovascular anti-infective anti-inflammatory markets. Squibb investming 75 mln dlrs Cetus' research five years. "Squibb put 75 mln dlrs research development happen equity position package simply demonstrate seriousness partnership" Fildes. Reuter 